Real-World Reductions in Oral Corticosteroid Use in the USA Following Mepolizumab Therapy for Severe Asthma

BACKGROUND: Patients with severe asthma often require oral corticosteroid (OCS) treatment. Clinical trials have demonstrated that mepolizumab can reduce OCS dependence, but real-world data are limited. OBJECTIVE: To evaluate the impact of mepolizumab on OCS use, asthma exacerbations, and asthma exac...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Asthma Allergy
Hauptverfasser: Silver, Jared, Bogart, Michael, Packnett, Elizabeth, Wu, Juan, McMorrow, Donna, Hahn, Beth
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove 2020
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7751313/
https://ncbi.nlm.nih.gov/pubmed/33364788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S275944
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge